Burkitt Leukemia

• CLINICAL_TRIALS research · 2026-03-27
  Clinical Trial Update: A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations [Phase 2]

  Phase 2 study of CPI-613 (devimistat) for relapsed or refractory Burkitt lymphoma/leukemia and high-grade B-cell lymphoma with high-risk tra…

• CLINICAL_TRIALS trial_result · 2026-02-17
  Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia [Phase 2]

  Phase 2 clinical trial update describing a combination chemotherapy regimen for relapsed or refractory acute lymphoblastic leukemia, lymphob…

• CLINICAL_TRIALS trial_result · 2026-02-09
  Clinical Trial Update: Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients [Phase 3]

  A Phase 3 intergroup trial evaluating rituximab in high-risk pediatric patients with B-cell non-Hodgkin lymphoma or Burkitt leukemia has com…

• CLINICAL_TRIALS research · 2025-10-15
  Clinical Trial Update: Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant [Phase 2]

  Phase 2 clinical trial evaluating naive T cell depletion to prevent chronic graft-versus-host disease in children and young adults receiving…

• CLINICAL_TRIALS trial_result · 2022-08-19
  Clinical Trial Update: Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults [Phase 4]

  Phase 4 clinical trial update for newly diagnosed mature B-ALL, Burkitt's lymphoma, and other high-grade lymphomas in adults has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-05-03
  Clinical Trial Update: Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

  Phase 2 trial evaluating combination chemotherapy and Ofatumumab in adults with acute lymphoblastic leukemia or lymphoblastic lymphoma compl…

• CLINICAL_TRIALS trial_result · 2018-09-17
  Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia [Phase 2]

  Phase 2 trial evaluating combination chemotherapy with rituximab for newly diagnosed Burkitt's lymphoma or leukemia has completed; results p…

• CLINICAL_TRIALS trial_result · 2014-10-22
  Clinical Trial Update: Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia [Phase 2]

  Phase 2 trial evaluating rituximab with chemotherapy and filgrastim in Burkitt's lymphoma or Burkitt's leukemia; study completed with result…

• CLINICAL_TRIALS trial_result · 2013-12-19
  Clinical Trial Update: Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia [Phase 2]

  Phase 2 trial evaluating a combination chemotherapy regimen for Burkitt's lymphoma or Burkitt's leukemia; the study status is completed.